Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Study confirms 2 vaccine doses protect children from chickenpox

05.01.2011
Two doses of the varicella, or chickenpox, vaccine provide excellent protection in children against this highly contagious and, in some cases, severe disease. To be published in the February 1 issue of The Journal of Infectious Diseases, the findings support the two-dose vaccine regimen recommended in the United States since 2006. (Please see below for a link to the study online.)

The Centers for Disease Control and Prevention (CDC) began recommending a single dose of varicella vaccine in children aged 1 to 13 years old in 1995. Although the incidence of varicella fell by 90 percent after introduction of the vaccine, there was a high rate of breakthrough varicella illness in immunized children and continuing outbreaks of varicella among children despite high rates of vaccination. Studies also showed that the single-dose vaccine's effectiveness was less than 90 percent. Given the evidence, CDC in 2006 began recommending a second dose of the vaccine for children 4 to 6 years old.

Although data suggest that two doses of varicella vaccine are associated with higher levels of antibody than is one dose, this study is the first to assess the clinical effectiveness of two doses of the vaccine in the general population. Eugene D. Shapiro, MD, and colleagues at Yale University and collaborators at Columbia University conducted active surveillance in an area in Connecticut and discovered 71 cases of varicella in children aged 4 or older. None of the children had received two doses of vaccine, 66 (93 percent) had received one dose, and 5 (7 percent) had received no vaccine.

The investigators then compared the effectiveness of two doses of vaccine versus one dose in a case-control study, using 140 matched controls. The effectiveness of one dose in preventing varicella was 86.0 percent, while the effectiveness of two doses was 98.3 percent. According to Dr. Shapiro, "The odds of developing varicella were 95 percent lower in children who had received two doses of the vaccine compared with those who had received only one."

The results of this study suggest that countries immunizing children with only one dose of varicella vaccine should consider changing to a two-dose regimen. But, the authors emphasized, "There should be continued monitoring of the effectiveness of two doses to assure that its high degree of effectiveness is sustained."

In an accompanying editorial, David W. Kimberlin, MD, of the University of Alabama at Birmingham, agreed with the study authors, noting that this study is the first to evaluate the effectiveness of two doses of varicella vaccine in a "real-world" setting. "The high effectiveness of 98.3 percent found in this investigation supports the programmatic change instituted four years ago," Dr. Kimberlin noted.

Fast Facts:

1) In this study, the odds of developing varicella (chickenpox) were 95 percent lower in children > 4 years of age who had received two doses of the varicella vaccine compared with those who had received only one dose.

2) Of the 71 cases of varicella noted in the study, none of the subjects had received two doses of vaccine.

3) The effectiveness of two doses of vaccine in protecting against varicella in the study population was 98.3 percent.

NOTE: The study and the accompanying editorial are available online. They are embargoed until 12:01 a.m. EST on Wednesday, Jan. 5, 2011:

"Effectiveness of 2 Doses of Varicella Vaccine in Children"
http://www.oxfordjournals.org/our_journals/jid/jiq052.pdf
"Control of Varicella Disease, Version 2.0"
http://www.oxfordjournals.org/our_journals/jid/jiq053.pdf
Founded in 1904, The Journal of Infectious Diseases is the premier publication in the Western Hemisphere for original research on the pathogenesis, diagnosis, and treatment of infectious diseases; on the microbes that cause them; and on disorders of host immune mechanisms. Articles in JID include research results from microbiology, immunology, epidemiology, and related disciplines. It is published under the auspices of the Infectious Diseases Society of America (IDSA). Based in Arlington, Va., IDSA is a professional society representing more than 9,000 physicians and scientists who specialize in infectious diseases.

John Heys | EurekAlert!
Further information:
http://www.idsociety.org

More articles from Studies and Analyses:

nachricht Real-time feedback helps save energy and water
08.02.2017 | Otto-Friedrich-Universität Bamberg

nachricht The Great Unknown: Risk-Taking Behavior in Adolescents
19.01.2017 | Max-Planck-Institut für Bildungsforschung

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Breakthrough with a chain of gold atoms

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

Im Focus: DNA repair: a new letter in the cell alphabet

Results reveal how discoveries may be hidden in scientific “blind spots”

Cells need to repair damaged DNA in our genes to prevent the development of cancer and other diseases. Our cells therefore activate and send “repair-proteins”...

Im Focus: Dresdner scientists print tomorrow’s world

The Fraunhofer IWS Dresden and Technische Universität Dresden inaugurated their jointly operated Center for Additive Manufacturing Dresden (AMCD) with a festive ceremony on February 7, 2017. Scientists from various disciplines perform research on materials, additive manufacturing processes and innovative technologies, which build up components in a layer by layer process. This technology opens up new horizons for component design and combinations of functions. For example during fabrication, electrical conductors and sensors are already able to be additively manufactured into components. They provide information about stress conditions of a product during operation.

The 3D-printing technology, or additive manufacturing as it is often called, has long made the step out of scientific research laboratories into industrial...

Im Focus: Mimicking nature's cellular architectures via 3-D printing

Research offers new level of control over the structure of 3-D printed materials

Nature does amazing things with limited design materials. Grass, for example, can support its own weight, resist strong wind loads, and recover after being...

Im Focus: Three Magnetic States for Each Hole

Nanometer-scale magnetic perforated grids could create new possibilities for computing. Together with international colleagues, scientists from the Helmholtz Zentrum Dresden-Rossendorf (HZDR) have shown how a cobalt grid can be reliably programmed at room temperature. In addition they discovered that for every hole ("antidot") three magnetic states can be configured. The results have been published in the journal "Scientific Reports".

Physicist Dr. Rantej Bali from the HZDR, together with scientists from Singapore and Australia, designed a special grid structure in a thin layer of cobalt in...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Booth and panel discussion – The Lindau Nobel Laureate Meetings at the AAAS 2017 Annual Meeting

13.02.2017 | Event News

Complex Loading versus Hidden Reserves

10.02.2017 | Event News

International Conference on Crystal Growth in Freiburg

09.02.2017 | Event News

 
Latest News

Stingless bees have their nests protected by soldiers

24.02.2017 | Life Sciences

New risk factors for anxiety disorders

24.02.2017 | Life Sciences

MWC 2017: 5G Capital Berlin

24.02.2017 | Trade Fair News

VideoLinks
B2B-VideoLinks
More VideoLinks >>>